Market Overview

Wearable Subcutaneous Drug Delivery Markets, 2024 -


The "Wearable
Subcutaneous Drug Delivery"
report has been added to's

As new drugs become available for the treatment of an expanding list of
health conditions, drug developers have increasingly pursued packaging
and delivery options that simplify the administration process and
increase the efficiency and reliability with which the drug can be
introduced into the patient.

For injectable drugs, this pursuit has led to an accelerated evolution
in injection device design, creating new opportunities and choices for
drug marketers. As the administration of injectables moves increasingly
from practitioner offices and healthcare facilities to patient homes,
decisions regarding as-supplied packaging that were once considered
boilerplate have moved to the early stages of the development process.

A wide spectrum of device attributes, including form factor,
device-patient interaction, security and safety, dosing, activation,
off-device communication, and drug formulation factors have been
incorporated into drug injection devices. Over time, these initiatives
will come to be expected by patients in injectable drugs.

What You Will Learn

  • What wearable subcutaneous injection devices for drug delivery have
    been approved for marketing, and what are the key market segments,
    market dynamics and market demographics?
  • What are the therapeutic demand drivers for wearable drug delivery
  • What are the key design factors, material selection issues,
    technologies and market development issues?
  • What is the market today, who are the leaders, and what will it look
    like in 2024?
  • Who are the competitors and participants in the wearable subcutaneous
    drug delivery segment, and what are their product development
    activities, business strategies, and business alliances and
  • What is the importance of pharma-device alliances and design
    partnerships on wearable injector drug delivery injector drug delivery

Who Should Read This Report


  • Drug Developers
  • Device Suppliers
  • CMOs
  • Components/APIs
  • Testing/Validation
  • Clinical Trial Mgmt


  • Pharma Managers
  • Biotech Managers
  • Drug Marketers
  • Industry Strategists
  • Financial Analysts
  • Management Consultants


  • Clinical Managers
  • Drug Distributors
  • Pharma Regulators
  • FDA Consultants
  • Managed Care Managers

Key Topics Covered:

1. Executive Summary

2. SC Drug Delivery Market Segment Dynamics

  • Drug Development Trends
  • Drug Delivery Device Evolution
  • SC System Enabling Technologies
  • Wearable Patch Subcutaneous Design Factors
  • Device/System Architecture
  • Product Migration
  • Volumes & Viscosities
  • Device Electronics
  • Accuracy and Dosing Variability
  • Alerts and Patient Notification

3. Product Analysis and Assessments

4. Becton Dickinson

  • Omnipod (Insulet)
  • Patch Pumps (Sensile Medical)
  • SmartDose (West Pharmaceuticals)
  • YpsoDose (Ypsomed)
  • Electronic Semi-disposable
  • E3D Patch Pump (Elcam)
  • Mechanical Disposable
  • Enable Injector
  • Captive Devices
  • sc2Wear Infusor (scPharmaceuticals)
  • PatchPump (SteadyMed)
  • Product Specific Devices
  • Neulasta OnPro Injector (Amgen)s

5. Therapeutic Segment Analysis and Market Data

  • Blood Factors
  • Cardiovascular
  • Diabetes
  • Immunoglobulins
  • Reproductive Health
  • Market Factors
  • Regulatory Issues
  • IP and Patents
  • Healthcare Economics

6. Company Profiles

  • Amgen
  • Becton Dickinson
  • Elcam
  • Insulet
  • Sensile Medical
  • SteadyMed
  • West Pharmaceuticals
  • Ypsomed
  • scPharmaceuticals

For more information about this report visit

View Comments and Join the Discussion!